Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms JP-5 |
Target |
Mechanism JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC70H94F2N10O12S |
InChIKeyHJJLFXNMMWGGEX-TWOTYITNSA-N |
CAS Registry- |